Carraghenates/Titanium dioxide/zinc oxide/Lidocaine

角菜酸酯/二氧化钛/氧化锌/利多卡因

Report date: 2026/02/13 10:40:21

Base Information

Drug NameCarraghenates/Titanium dioxide/zinc oxide/Lidocaine
Drug Alias Name复方角菜酸酯太宁
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockersVirus internalization inhibitors
TargetsSodium channel alpha subunit
Therapy Area/IndicationsHemorrhageHyperemiaPruritus Ani
Global Approved IndicationsHemorrhageHyperemiaPruritus Ani
Approved Indications in ChinaHemorrhageHyperemiaPruritus Ani
Original Approved Country/TerritoryMainland China
Original Approved Date2000/10/24
Country/TerritoryMainland China
CombinationsYes CarrageenanTitanium dioxidezinc oxide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson-Msd Consumer Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson-Msd Consumer Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsHemorrhageHyperemiaPruritus Ani
Inactive IndicationsN/A

Other Information

ATC CodeA
Related LinksN/A